Pekin Singer Strauss Asset Management IL Sells 51 Shares of CVS Health Corporation (CVS)
Pekin Singer Strauss Asset Management IL cut its holdings in shares of CVS Health Corporation (NYSE:CVS) by 1.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,639 shares of the pharmacy operator’s stock after selling 51 shares during the quarter. Pekin Singer Strauss Asset Management IL’s holdings in CVS Health Corporation were worth $212,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Gemmer Asset Management LLC boosted its position in CVS Health Corporation by 15.3% during the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after acquiring an additional 200 shares during the last quarter. TB Alternative Assets Ltd. acquired a new position in CVS Health Corporation during the second quarter worth about $121,000. SRS Capital Advisors Inc. boosted its position in CVS Health Corporation by 48.2% during the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after acquiring an additional 734 shares during the last quarter. Grace & White Inc. NY acquired a new position in CVS Health Corporation during the second quarter worth about $199,000. Finally, Nadler Financial Group Inc. acquired a new position in CVS Health Corporation during the second quarter worth about $202,000. Hedge funds and other institutional investors own 81.46% of the company’s stock.
Shares of CVS Health Corporation (NYSE:CVS) opened at 72.63 on Wednesday. The stock has a market capitalization of $73.83 billion, a P/E ratio of 14.47 and a beta of 0.92. The stock has a 50 day moving average of $79.27 and a 200-day moving average of $78.87. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $88.84.
CVS Health Corporation (NYSE:CVS) last released its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The business had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. During the same period last year, the company earned $1.32 earnings per share. The company’s quarterly revenue was up 4.5% on a year-over-year basis. Equities research analysts predict that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Investors of record on Tuesday, October 24th will be given a $0.50 dividend. The ex-dividend date of this dividend is Monday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.75%. CVS Health Corporation’s dividend payout ratio is presently 39.92%.
In related news, CFO David M. Denton sold 237,078 shares of the firm’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $79.65, for a total value of $18,883,262.70. Following the sale, the chief financial officer now directly owns 141,096 shares of the company’s stock, valued at $11,238,296.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Thomas M. Moriarty sold 20,547 shares of the firm’s stock in a transaction that occurred on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the completion of the sale, the executive vice president now directly owns 43,178 shares in the company, valued at $3,504,758.26. The disclosure for this sale can be found here. Insiders sold 716,625 shares of company stock worth $58,318,431 over the last three months. Corporate insiders own 0.61% of the company’s stock.
A number of equities analysts recently weighed in on CVS shares. Royal Bank Of Canada started coverage on shares of CVS Health Corporation in a research report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price target on the stock. Leerink Swann set a $90.00 price target on shares of CVS Health Corporation and gave the stock a “buy” rating in a research report on Tuesday, June 27th. Robert W. Baird restated an “outperform” rating and set a $90.00 price target on shares of CVS Health Corporation in a research report on Monday, August 14th. Loop Capital started coverage on shares of CVS Health Corporation in a research report on Thursday, August 24th. They set a “hold” rating and a $83.00 price target on the stock. Finally, Jefferies Group LLC lifted their target price on shares of CVS Health Corporation from $82.00 to $86.00 and gave the stock a “hold” rating in a research note on Friday, September 15th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and sixteen have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $89.68.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.